It took months for the Biden administration to admit that COVID could have come from a lab in spite of all the evidence.
And now finally the FDA is admitting that the Johnson and Johnson vaccine may be linked to a rare, incurable disorder: Guillain-Barre syndrome.
The Food and Drug Administration (FDA) announced a new warning on the Johnson & JohnsonCOVID-19vaccineand a possible link to Guillain-Barré, a rare autoimmune nerve disorder. The agency revised the vaccine’s accompanying fact sheets to reflect an increased risk of the disorder following vaccination.
The warning comes after about 100 preliminary reports of Guillain-Barré cases against a backdrop of about 12.5 million Johnson & Johnson doses administered, the FDA said in a statement Monday. Of the total, 95 cases were serious and involved hospitalization, with one reported death. However, the FDA stopped short of pinning a causal relationship between the vaccine and the rare disorder.
“Although the available evidence suggests an association between the Janssen vaccine and increased risk of GBS, it is insufficient to establish a causal relationship,” the statement reads, later adding, “Importantly, the FDA has evaluated the available information for the Janssen COVID-19 Vaccine and continues to find the known and potential benefits clearly outweigh the known and potential risks.”
Are they for real?
You could get an incurable disease from this vaccine but we still think you should take it?
That’s like telling someone, “Your Bungie is frayed and it’s a 100-foot drop but we still think you should jump!” What the heck?
Here’s what the Mayo Clinic has to say about Guillain-Barre syndrome.
Guillain-Barre (gee-YAH-buh-RAY) syndrome is a rare disorder in which your body’s immune system attacks your nerves. Weakness and tingling in your extremities are usually the first symptoms.
These sensations can quickly spread, eventually paralyzing your whole body. In its most severe form Guillain-Barre syndrome is a medical emergency. Most people with the condition must be hospitalized to receive treatment.
The exact cause of Guillain-Barre syndrome is unknown. But two-thirds of patients report symptoms of an infection in the six weeks preceding. These include respiratory or a gastrointestinal infection or Zika virus.
There’s no known cure for Guillain-Barre syndrome, but several treatments can ease symptoms and reduce the duration of the illness. Although most people recover from Guillain-Barre syndrome, the mortality rate is 4% to 7%. Between 60-80% of people are able to walk at six months. Patients may experience lingering effects from it, such as weakness, numbness or fatigue.
If you don’t die from it, there’s a 60-80% chance that you may be able to walk after six months!
Some reactions from Twitter:
I guess we will find out … after six months.
Source for Story: